Health & Biotech
HealthInvest returns to Sydney, highlighting emerging ASX healthcare talent
Transformative journey driving Argent BioPharma’s growth and US listing plans
Biocurious: ASX drug developers see silver lining in FDA’s interventionist approach
Health Check: Polynovo shares go crackers after positive US reimbursement changes
Dr Boreham’s Crucible: CSL layer cake fails investor taste test – what’s next on the menu?
Lumos scores BARDA funding for paediatric study, secures follow-on contract with Aptatek
Island submits key US FDA meeting request for new antiviral asset Galidesivir
Health Check: 4D Medical wins ‘historic’ FDA clearance for lung imaging tool
Health Kick Podcast: Fresh data keeps Neurizon on track in ALS fight
Imagion boosts board with Dimerix boss Dr Nina Webster
Hot Money Monday: Some crucial biotech updates you might have missed last week
Scott Power: ASX healthcare sector falls as strain of reporting season takes a toll
Arovella Therapeutics scores US patent for iNKT blood cancer treatment
Health Check: Angry investors birch Telix shares after third US regulatory setback
Rhythm teams up with Know Your Lemons to expand geneType breast cancer risk test
Clever Culture expands pharma reach on validating smaller APAS contact plate
Health Check: Sigma’s success prescription is double-digit sales growth, pleasing merger cost savings
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
